10-K: Elite Health Systems Inc. Focuses on Medicare Advantage Plans Despite Ongoing Losses and Going Concern Uncertainty

Elite Health Systems Inc. is concentrating on developing Medicare Advantage plans in California and Nevada, despite reporting a net loss of $2.055 million in 2024 and facing substantial doubt about its ability to continue as a going concern.

Summary

• Elite Health Systems Inc. (formerly U.S. NeuroSurgical Holdings, Inc.) is shifting its focus to developing Medicare Advantage plans through its subsidiaries, primarily targeting California and Nevada.
• The company reported a net loss of $2.055 million in 2024, compared to a loss of $816,000 in 2023.
• SG&A expenses increased by 134% to $1.793 million in 2024 due to costs associated with applying for a Medicare Advantage plan in California.
• As of December 31, 2024, the company had an accumulated deficit of $4.445 million and working capital of $3.917 million.
• The company raised $5.8 million through a private placement in 2024, closing in January 2025, issuing 11,650,000 shares of common stock.
• Elite Health Plan, Inc. has submitted documentation for a Knox-Keene license to offer managed health care plans in California, with a final submission of plan details expected in June 2025.
• The company acknowledges substantial doubt about its ability to continue as a going concern but believes its plans to establish managed healthcare plans will alleviate this concern.
• As of March 24, 2025, there were 21,409,924 shares of the company's common stock outstanding.

Sentiment

Score: 4

Explanation: The document presents a mixed picture. While the company is actively pursuing a growth strategy in the Medicare Advantage market and has secured funding through a private placement, it is also facing significant financial challenges, including substantial losses and concerns about its ability to continue as a going concern. The sentiment is therefore cautiously negative.

Positives

• The company successfully raised $5.8 million through a private placement, providing capital for its Medicare Advantage plan initiatives.
• Elite Health Plan, Inc. is actively pursuing a Knox-Keene license in California, a key step towards operating a managed care organization.
• The company has identified and is relying on experienced personnel, consultants and other industry-centric service providers and experts to assist Elite Health in applying for and securing appropriate licensing and establishing the necessary corporate infrastructure to operate Medicare Advantage plans in California.
• The company has working capital of $3,917,000 as of December 31, 2024, compared to negative working capital of $80,000 at December 31, 2023.

Negatives

• The company reported a significant net loss of $2.055 million in 2024, indicating ongoing financial challenges.
• There is substantial doubt about the company's ability to continue as a going concern, raising concerns about its long-term viability.
• Elite Health currently has no revenue and will not be in a position to generate significant revenue while it seeks to obtain a license to operate a Medicare Advantage plan in California.
• The company is dependent on obtaining necessary approvals and gaining access to a sufficient network of providers and enrolling a critical level of subscribers.

Risks

• The company's success is heavily dependent on securing a Medicare Advantage license in California, which is not guaranteed.
• The company faces intense competition in the managed care market, dominated by larger, more established players.
• Failure to manage medical care costs effectively could negatively impact profitability.
• Cybersecurity threats and data breaches pose a significant risk to the company's operations and sensitive information.
• The company's reliance on third-party vendors and providers introduces vulnerabilities and potential disruptions.
• The company's financial performance is subject to regulatory changes and government audits.
• The company's stock price is volatile and may be affected by market fluctuations and industry-specific factors.
• The company is dependent on the leadership of key employees, and the loss of their expertise could negatively impact operations.
• The company has disclosed material weaknesses in its financial controls and procedures for an extended period of time.

Future Outlook

The company intends to focus on establishing a managed care organization that will develop and operate Medicare Advantage plans for seniors in California, Nevada, and other areas in the U.S., and to pursue other opportunities related to this activity.

Management Comments

• Management believes its plan alleviates the substantial doubt and that it will be successful in its planned business initiatives and will be able to continue as a going concern through at least the next twelve months.

Industry Context

The Medicare Advantage market is experiencing significant growth, driven by an aging population. The market is dominated by major traditional health insurance entities like UnitedHealth Group and Humana. The Congressional Budget Office (CBO) projects that the share of all Medicare beneficiaries enrolled in Medicare Advantage plans will rise to 64% by 2034.

Comparison to Industry Standards

• The report mentions that the Medicare Advantage market is dominated by UnitedHealth Group and Humana, which account for nearly half of all Medicare Advantage enrollees nationwide.
• The company acknowledges that it will operate in highly competitive markets against organizations ranging from startups to Fortune 50 global enterprises.
• The company expects to compete on the quality and value it provides, including product and service innovation, use of technology, consumer and provider engagement, and sales, marketing and pricing.

Management Changes

Legal Proceedings

• The company is subject to lawsuits, investigations and potential claims arising out of the ordinary conduct of its business.
• The company is not currently involved in any material litigation.

Related Party Transactions

• The company recorded compensation with directors and officers of the company for the year ended December 31, 2024 consisting of stock grants valued at $0.50 per share of 75,000 for each of directors St. Lawrence and Leimkuhler; 75,000 for Executive Director Ms. Reheer; and 250,000 for CEO and Board Chair, Dr. Jeereddi.
• The company compensates Physician Support Services, Inc (PSS) for services of Ms. Reheer and others as well as the sharing of rental space and other services; Dr. Jeereddi is the majority owner of PSS and Ms. Reheer is the Executive Director.

Stakeholder Impact

• Shareholders face the risk of dilution from future equity offerings.
• Employees' job security may be affected by the company's financial challenges.
• Customers (potential Medicare Advantage plan members) may be impacted by the company's ability to secure necessary licenses and provide quality care.
• Suppliers and creditors face the risk of non-payment if the company's financial situation deteriorates.

Next Steps

• Elite Health Plan, Inc. will continue to pursue a Knox-Keene license in California.
• The company will focus on establishing a network of providers and enrolling subscribers for its Medicare Advantage plans.
• The company will monitor its financial performance and seek additional capital if needed.

Key Dates

Keywords

Medicare Advantage, Elite Health Systems, Knox-Keene license, Managed care, Healthcare, Private placement, Going concern, Financial results, California, Nevada